Skip to main content
RUA LIFE SCIENCES PLC logo

RUA LIFE SCIENCES PLC — Investor Relations & Filings

Ticker · RUA ISIN · GB0033360586 LEI · 213800BMVB22PVOJ9Z28 IL Manufacturing
Open in API
Filings indexed 200 across all filing types
Latest filing 2023-12-13 Report Publication Anno…
Country GB United Kingdom
Listing IL RUA

About RUA LIFE SCIENCES PLC

https://rualifesciences.com/

RUA Life Sciences is a medical device group focused on the application of its proprietary long-term implantable polymer, Elast-Eon™, a biostable polyurethane. The company operates through four integrated businesses to develop, manufacture, and license medical device solutions. RUA Biomaterials is responsible for licensing the Elast-Eon™ technology. RUA Medical provides end-to-end contract development and manufacturing services, specializing in implantable fabrics. RUA Vascular develops large-bore, polymer-sealed vascular grafts and soft tissue patches. RUA Structural Heart is engaged in the development of next-generation tri-leaflet polymeric heart valves. The group's collective mission is to improve patient outcomes by enabling and enhancing medical devices through its advanced polymer technology.

Recent filings

Filing Released Lang Actions
Investor Presentation
Report Publication Announcement Classification · 1% confidence The document is a formal announcement disseminated via RNS (RNS Number: 6846W). The core content announces that the company will conduct an 'Investor Presentation' on December 19, 2023, which will follow the publication of their interim results. Since the document is an announcement about a future presentation and provides registration links, it fits the definition of a Report Publication Announcement (RPA) or potentially an Investor Presentation (IP). Given the explicit mention of announcing the event ('Investor Presentation - 19 December 2023') and the short length (2342 chars), it is primarily an announcement regarding the publication/event of investor materials. However, the content is specifically about an 'Investor Presentation'. If the presentation itself were attached, IP would be better, but since this is the announcement *of* the presentation event, RPA is a strong candidate. Reviewing the definitions: IP is the presentation itself. RPA is the announcement regarding the timing/release of reports. Since this announces the timing and details of the Investor Presentation, RPA is the most accurate classification for this specific filing type, which is an announcement about an upcoming investor event/material release.
2023-12-13 English
Temporary suspension of trading
Delisting Announcement Classification · 1% confidence The document is identified by the 'RNS Number' header and contains standard boilerplate language from RNS, the news service of the London Stock Exchange, including the disclaimer about the Financial Conduct Authority (FCA) approval. The content announces a 'Temporary suspension of trading' for RUA Life Sciences Plc, referencing a London Stock Exchange Market Notice (N05/23). This type of immediate, non-periodic, market-sensitive announcement that doesn't fit into specific financial reporting categories (like 10-K, ER, or IR) is best classified as a general regulatory announcement. Since it is a direct notification to the market via the RNS system, the most appropriate code is RNS (Regulatory Filings/General Regulatory Announcements). The document length is substantial (6408 chars), so it is not a simple RPA (Report Publication Announcement).
2023-12-11 English
Result of Retail Offer
Share Issue/Capital Change Classification · 1% confidence The document is identified by the RNS Number header and the use of 'RNS Number' and 'RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' This indicates it is a regulatory announcement distributed via the London Stock Exchange's RNS service. The content details the 'Result of Retail Offer,' including the issuance of new shares, total voting rights, and admission to trading. This is a specific corporate action announcement related to capital raising/share issuance, but because it is distributed via RNS and is a formal announcement of a corporate event rather than a full financial report (like 10-K or IR), it fits best under the general regulatory announcement category, RNS, or potentially CAP (Capital/Financing Update). Given the structure and the explicit RNS branding, RNS is the most accurate classification for the *type of filing* itself, although the subject matter is capital change. Since the document is a formal announcement of a specific corporate action (share issuance/offer result) distributed via a regulatory news service, and it is not extremely short (over 6000 chars), it is a primary regulatory filing. If 'CAP' were chosen, it would describe the *subject*, but 'RNS' describes the *format/source*. Since the definitions prioritize specific content types, and this is clearly a capital raising result, 'CAP' is a strong candidate. However, the presence of the RNS header and the nature of the announcement (a formal market update) often defaults to RNS if a more specific category like 'SHA' (Share Issue) or 'POS' (Transaction in Own Shares) doesn't perfectly fit the description (this is a Retail Offer resulting in new shares, which is closer to SHA or CAP). Since it is a result of an offer raising proceeds (£0.31 million, £4.4 million total), it strongly relates to financing activities. I will classify it as CAP (Capital/Financing Update) as the core subject matter is the result of a capital raise, which is more specific than the general RNS fallback.
2023-12-08 English
Result of Placing and Subscription
Capital/Financing Update Classification · 1% confidence The document is an official announcement disseminated via RNS (RUA Life Sciences PLC, RNS Number: 3079V, dated 01 December 2023). The content explicitly details the successful completion of a fundraising effort, specifically a 'Placing and Subscription,' raising gross proceeds of approximately £4.0 million. This involves the conditional placing of shares at a specific issue price and mentions the intention of directors to subscribe for additional shares. This activity directly relates to raising capital and changing the company's financing structure. Therefore, the most appropriate classification is Capital/Financing Update (CAP). Although it is distributed via RNS, the core subject matter is financing, making CAP more specific than the general RNS fallback.
2023-12-01 English
Retail Offer
Capital/Financing Update Classification · 1% confidence The document is an official announcement disseminated via RNS (RNS Number : 2951V) by RUA Life Sciences PLC. The content explicitly details a 'Retail Offer to raise up to £0.75 million via Bookbuild Platform' involving the issuance of new ordinary shares at a specific price. This action—raising capital through the issuance of new shares—falls directly under the definition of a financing activity or capital structure change. This aligns perfectly with the 'Capital/Financing Update' category (CAP). Although it is an announcement, it is the primary document detailing the financing terms, not just announcing that a separate, larger report is attached (which would suggest RPA or RNS). Since it is a specific announcement about a capital raise, CAP is the most precise classification.
2023-11-30 English
Placing and Subscription
Capital/Financing Update Classification · 1% confidence The document is an RNS announcement (RNS Number : 2949V) from RUA Life Sciences PLC dated November 30, 2023. The core content announces a 'Placing and Subscription to raise a minimum of £4.1 million' and a 'Retail Offer to raise up to £0.75 million' at a specific price per share. This clearly details a fundraising activity involving the issuance of new shares. This aligns directly with the definition of 'Capital/Financing Update' (CAP). Although it mentions a future General Meeting and the expected publication of a Circular, the primary purpose of this immediate announcement is the capital raise itself, not just the announcement of a report (which would be RPA or RNS). Since CAP is a specific category for fundraising/financing activities, it is the most appropriate classification over the general RNS fallback.
2023-11-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.